The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B.
about
Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel DiseaseThe Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel DiseaseBiological and Pharmacological Aspects of the NK1-ReceptorNeurogenic inflammation after traumatic brain injury and its potentiation of classical inflammationSubstance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosisSCRG1 suppresses LPS-induced CCL22 production through ERK1/2 activation in mouse macrophage Raw264.7 cellsThe role of substance P in stress and anxiety responses.Substance P and Substance P receptor antagonists in the pathogenesis and treatment of affective disorders.The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disordersMetalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes.Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytesRole of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxideRegulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter.Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study.Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cellsSerum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats.Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neuronsA role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage.Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activationNeurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi.Intestinal immune response to human Cryptosporidium sp. infection.Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells.Substance P is required for the pathogenesis of EMCV infection in miceKeratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways.Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.The role of substance p in ischaemic brain injury.Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndrome.Neuropeptide substance P and the immune response.A novel synthetic compound 4-acetyl-3-methyl-6-(2-bromophenyl)pyrano[3,4-c]pyran-1,8-dione inhibits the production of nitric oxide and proinflammatory cytokines via the NF-κB pathway in lipopolysaccharide-activated microglia cells.The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment.Substance P receptor in U373 MG human astrocytoma cells activates mitogen-activated protein kinases ERK1/2 through Src.Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.Signal transduction through substance P receptor in human glioblastoma cells: roles for Src and PKCdelta.Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells.Quantitative proteomic and transcriptional analysis of the response to the p38 mitogen-activated protein kinase inhibitor SB203580 in transformed follicular lymphoma cells.Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases.Role of mitogen-activated protein kinase family in serum-induced leukaemia inhibitory factor and interleukin-6 secretion by bone marrow stromal cells.Modulation of somatostatin receptors, somatostatin content and Gi proteins by substance P in the rat frontoparietal cortex and hippocampus.
P2860
Q26741037-C0861B0B-C437-420F-9FD6-A6F2E1EA4E2BQ26774660-4E2469D1-A7A0-4D9F-A675-EA0E7DB4DF2EQ26784074-C0DD3E1A-992F-45F2-AC0C-D58FB24188C5Q28069959-E18AD7A0-CBBF-4C91-88B1-04C7F38FDF53Q33635087-353253C8-ADCE-47BE-8594-766006EEF963Q33702432-59EF0017-2186-46DA-B3AD-E1F791600D91Q33997424-CC69C5EC-AB46-4455-B916-A001BA333508Q34190355-99D441B8-4F51-4E25-8C7E-8668A8674614Q34259043-922CC1F5-EBB2-4345-B129-97AA33A6B9B5Q34342202-E1DA8847-BC02-4AD2-AAF0-5BF0B6BD5555Q34597098-513A1F2C-9D10-4843-8E9F-269207379523Q34714207-C43E3D9E-BA4A-41F7-B99F-0B60C6B0DBF7Q34809257-101D2629-6BEB-42E1-8329-D93E1164F4B0Q35410165-5E0860E6-C8DC-414D-988D-A3C10C74AB13Q35545383-B4D0D1B7-4833-455F-B2CC-B08977D80902Q35584890-A9B92956-5FF7-4733-8435-78616D470C89Q35928366-07B00201-8E83-475E-B4A1-064602A1F36DQ36249124-4B60606E-AB6D-4684-B068-5CD5EA092A9DQ36449385-23881A5A-6EE1-4D92-9AC2-0F558F5296DCQ36471141-AF70E47E-9BD5-4E1A-9E06-14A09ABB1B62Q36590618-5F7B1AE5-6C2A-4F76-95EE-5D74D154C22FQ36828595-F66B140D-175E-4B6C-9826-5AA6EA0DBEEDQ36984727-350046A9-0DC6-4393-ABF6-2860D259F5C9Q36994010-C4A1DFBA-57E8-44FB-BE7D-474618E498E3Q37186717-533E94B3-C9BE-449B-A7BB-7B266420D1D0Q37237647-FB28B453-0F44-4CD9-BFD3-946518B1C0E0Q37593097-F8944B3B-99F6-490B-A549-1F2937214DD1Q38222871-52EAFFCC-36E1-4C7B-AD4C-C81103AAC346Q38531668-9762D70B-515A-4A75-A6BE-B42A059F920BQ38868323-61433575-5B5D-419C-B418-9F7674898F29Q39200198-63F8ACF0-EBC4-4927-BC6F-6575D25897D8Q39888147-0AE2FE98-42B7-48E3-B844-C2F9B522F852Q40032761-500C2D9A-16EB-45E2-8C1B-3B537A125B54Q40085168-25D12182-DF94-407A-BBAE-780999A29D14Q40398377-FE14BD2D-A194-46A9-BA9F-43ADD397B30FQ40433980-6D986299-53DE-48CC-95C3-C2E28FE118EFQ40550748-818FC204-E2B5-4A11-840E-48A57D7C33C5Q40711853-6DB527DD-D9A8-49B5-8360-AA74AE62D937Q40715056-4C939E38-C5C6-49F2-9174-FCDE4EA1E0A9Q42528714-EF399508-5273-4B62-A70F-D22AF339401A
P2860
The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The neuropeptide substance P a ...... independently from NF-kappa B.
@ast
The neuropeptide substance P a ...... independently from NF-kappa B.
@en
type
label
The neuropeptide substance P a ...... independently from NF-kappa B.
@ast
The neuropeptide substance P a ...... independently from NF-kappa B.
@en
prefLabel
The neuropeptide substance P a ...... independently from NF-kappa B.
@ast
The neuropeptide substance P a ...... independently from NF-kappa B.
@en
P2093
P1476
The neuropeptide substance P a ...... independently from NF-kappa B.
@en
P2093
P304
P356
10.4049/JIMMUNOL.165.10.5606
P407
P577
2000-11-01T00:00:00Z